# Cisplatin Plus One-Day 24-hour Infusion of High-Dose 5-Fluorouracil for Stage IVB, Recurrent or Metastatic Carcinoma of the Uterine Cervix

> **NCT02207660** · — · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 30 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Cisplatin,P-HDFL

## Key facts

- **NCT ID:** NCT02207660
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02207660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02207660, "Cisplatin Plus One-Day 24-hour Infusion of High-Dose 5-Fluorouracil for Stage IVB, Recurrent or Metastatic Carcinoma of the Uterine Cervix". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02207660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*